Despite Roche's sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says

1st February 2024 Uncategorised 0

Despite Roche’s sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says
aliu
Thu, 02/01/2024 – 10:50

More: Despite Roche's sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says
Source: fierce